|
SGOL1 expression based on
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.373800E-01 |
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.531600E-01 |
| Normal-vs-Stage2 |
5.140000E-02 |
| Normal-vs-Stage3 |
3.007200E-01 |
| Normal-vs-Stage4 |
5.085200E-01 |
| Stage1-vs-Stage2 |
2.842400E-04 |
| Stage1-vs-Stage3 |
4.020600E-01 |
| Stage1-vs-Stage4 |
9.313800E-01 |
| Stage2-vs-Stage3 |
2.072200E-02 |
| Stage2-vs-Stage4 |
1.271880E-02 |
| Stage3-vs-Stage4 |
5.006400E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.578200E-01 |
| Normal-vs-AfricanAmerican |
2.119600E-01 |
| Normal-vs-Asian |
3.757600E-01 |
| Caucasian-vs-AfricanAmerican |
2.208000E-01 |
| Caucasian-vs-Asian |
6.819200E-01 |
| AfricanAmerican-vs-Asian |
5.615400E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.409000E-01 |
| Normal-vs-Female |
3.421800E-01 |
| Male-vs-Female |
9.522400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.652600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.061620E-01 |
| Normal-vs-Age(61-80Yrs) |
3.613400E-01 |
| Normal-vs-Age(81-100Yrs) |
6.457200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.804460E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.539600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.844630E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.102050E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.093500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.084390E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.905000E-01 |
| Classical-VS-Follicular |
2.246500E-04 |
| Classical-VS-Other |
3.247200E-01 |
| Classical-VS-Normal |
4.794600E-01 |
| Tall-VS-Follicular |
3.104100E-02 |
| Tall-VS-Other |
1.188820E-01 |
| Tall-VS-Normal |
8.715200E-01 |
| Follicular-VS-Other |
9.250200E-01 |
| Follicular-VS-Normal |
6.675800E-02 |
| Other-VS-Normal |
1.400630E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.222200E-01 |
| Normal-vs-N1 |
4.516600E-01 |
| N0-vs-N1 |
3.373200E-01 |
|
|
